Synthesis and magnetic transitions of rare-earth-free Fe–Mn–Ni–Si-based compositionally complex alloys at bulk and nanoscale

• Shabbir Tahir,
• Tatiana Smoliarova,
• Carlos Doñate-Buendía,
• Michael Farle,
• Natalia Shkodich and
• Bilal Gökce

Beilstein J. Nanotechnol. 2025, 16, 823–836, doi:10.3762/bjnano.16.62

• applications such as magnetic hyperthermia, where NPs are used in cancer therapy to induce localized heating when exposed to an alternating magnetic field [34]. However, producing CCAs at the nanoscale presents significant challenges. Traditional wet chemistry approaches often fail because of elemental

Polyurethane/silk fibroin-based electrospun membranes for wound healing and skin substitute applications

• Iqra Zainab,
• Zohra Naseem,
• Syeda Rubab Batool,
• Muhammad Waqas,
• Ahsan Nazir and
• Muhammad Anwaar Nazeer

Beilstein J. Nanotechnol. 2025, 16, 591–612, doi:10.3762/bjnano.16.46

• growth [175]. Zhou et al. focused on the fabrication of a novel composite membrane suitable for photothermal cancer therapy based on black phosphorus (BP) nanosheets because of their high biocompatibility and photothermal efficacy. SF was used as an exfoliating agent in stable liquid exfoliation with

Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• systems for cancer therapy, Kim et al. employed PLL in the synthesis of dually stabilised triblock copolymer micelles for the systemic delivery of phosphorothioate ASOs (metastasis associated lung adenocarcinoma transcript 1 lncRNA-targeted ASO (MALAT1-ASO) and GL3 luciferase-targeted ASO (GL3-ASO

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

• the context. In cancer therapy, reprogramming M2 macrophages into M1 enhances antitumor immunity, while in chronic inflammatory diseases, shifting from M1 to M2 facilitates inflammation resolution and tissue repair. This modulation can be achieved using small molecules, cytokines, or nanotechnology to

• target key signaling pathways [62]. M1 polarization in cancer therapy: Inducing or sustaining M1 polarization has proven effective in enhancing antitumor immunity. For example, chimeric antigen receptor macrophages (CAR-Ms), engineered by Klichinsky et al., sustained a robust M1 phenotype for over 40

• polarization by targeting TERF2IP, activating STAT3, and inhibiting NF-κB [70][71]. Innovative delivery systems for miRNAs have further advanced their therapeutic application. Liu et al. developed a hybrid nanovector with dual redox/pH-responsive properties for targeted miRNA delivery in cancer therapy. This

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• targeting specificity. Biomimetic nanocarriers demonstrate significant advancements in drug delivery systems against cancer therapy, Alzheimer's disease, autoimmune diseases, and viral infections such as COVID-19. Here, we address the therapeutic applications of biomimetic nanocarriers and their promising

• drug delivery in cancer therapy has been extensively studied in the pursuit of biocompatible components with high specificity. In this context, the integration of synthetic compounds such as nanoparticles with natural components, including membranes from various cell types (e.g., erythrocytes

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• therapeutic efficacy [44]. The development of PLHNPs for phytochemical delivery holds significant promise across various biomedical applications. PLHNPs can be utilized in cancer therapy, cardiovascular disease management, neurodegenerative disorder treatment, and other areas of medicine where phytochemicals

• in cancer therapy. This targeted delivery can increase the therapeutic efficacy of drugs while reducing side effects by minimizing off-target effects [61][62]. For instance, Garg et al. fabricated fucose ligand-decorated PLHNPs for the co-delivery of methotrexate and aceclofenac to achieve targeted

• and lipid-based carriers, providing stability, biocompatibility, and efficient drug encapsulation. Applications of stimuli-responsive PLHNPs are vast and impactful. In cancer therapy, they are used to deliver chemotherapeutic agents specifically to tumor sites, where the acidic microenvironment or

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

• Thi Ngoc Han Pham,
• Phuong-Thao Dang-Luong,
• Hong-Phuc Nguyen,
• Loc Le-Tuan,
• Xuan Thang Cao,
• Thanh-Danh Nguyen,
• Vy Tran Anh and
• Hieu Vu_Quang

Beilstein J. Nanotechnol. 2024, 15, 954–964, doi:10.3762/bjnano.15.78

• ). Additionally, the F127-folate@PLGA/CHL/IR780 nanoparticles exhibited a lower IC50 value against cancer cells than non-targeted F127@PLGA/CHL/IR780 nanoparticles. These findings suggest that the developed F127-folate@PLGA/CHL/IR780 nanoparticles hold promise as a theragnostic system for targeted cancer therapy

• on the half-life of nanoparticles that are currently in circulation. The optimal nanoparticle size for cancer therapy was observed to vary between 50 and 200 nm [39][40]. In our study, the nanoparticles were tailored for in vivo drug administration; thus, our nanoparticle size was suitable for use in

Electrospun polysuccinimide scaffolds containing different salts as potential wound dressing material

• Veronika Pálos,
• Krisztina S. Nagy,
• Rita Pázmány,
• Krisztina Juriga-Tóth,
• Bálint Budavári,
• Judit Domokos,
• Dóra Szabó,
• Ákos Zsembery and
• Angela Jedlovszky-Hajdu

Beilstein J. Nanotechnol. 2024, 15, 781–796, doi:10.3762/bjnano.15.65

• )/hydroxyapatite in orthopedics [1][2]. Biocompatible polymers are widely used in biomedical fields, such as stents, drug delivery systems in cancer therapy, bone repair, dentistry, joint prostheses, and tissue engineering [2][3][4][5][6]. Polymers have several advantageous properties for these applications as

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• cancer therapy agent, is included in the nanocomposite structure, and in vitro drug release studies under different pH conditions (pH 5.5 and 7.4) and photothermal activity at 808 nm NIR laser irradiation are investigated. The comprehensive integration of precise multifunctional nanoparticles design

• ’ magnetization cycle, as Bloch and Neel theorized [11][13]. Superparamagnetic iron oxide nanoparticles for drug delivery, diagnosis, and cancer therapy have gained wider acceptance in biomedical applications [14]. They have received notable attention in clinical applications such as early disease diagnosis (e.g

• of passive targeting in magnetic fields for photothermal cancer therapy, with PDA holds great promise for future applications. Therefore, surface modification with PDA is recognized as a favorable alternative for enhancing the biocompatibility of non-biodegradable substances. A study focused on

Nanocarrier systems loaded with IR780, iron oxide nanoparticles and chlorambucil for cancer theragnostics

• Phuong-Thao Dang-Luong,
• Hong-Phuc Nguyen,
• Loc Le-Tuan,
• Xuan-Thang Cao,
• Vy Tran-Anh and
• Hieu Vu Quang

Beilstein J. Nanotechnol. 2024, 15, 180–189, doi:10.3762/bjnano.15.17

• shown the potential application not only for cancer therapy but also for diagnosis. First, the NPs are internalized into the cells and gradually degrade in the low pH of the endosomes releasing CHL to interrupt the cell cycle. Second, the NPs carry both imaging agents, IR780 and IO, which are suitable

Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study

• Nittiya Suwannasom,
• Netsai Sriaksorn,
• Chutamas Thepmalee,
• Krissana Khoothiam,
• Ausanai Prapan,
• Hans Bäumler and
• Chonthida Thephinlap

Beilstein J. Nanotechnol. 2023, 14, 1127–1140, doi:10.3762/bjnano.14.93

• to confirm the uptake of CUR-HSA-MPs by cancer cells. Our studies revealed that HSA-MPs are potentially promising vehicles for increasing the solubility and bioavailability of CUR. Keywords: albumin submicron particles; cancer therapy; curcumin; drug delivery; Introduction Curcumin (CUR) is a

• into cancer cells, making them a promising option for cancer therapy. In addition, the surface modification of microparticles using substances such as antibodies and polymers suggests the potential for enhanced uptake, as previously demonstrated [55][56]. Nevertheless, further research should explore

Nanoarchitectonics of photothermal materials to enhance the sensitivity of lateral flow assays

• Elangovan Sarathkumar,
• Rajasekharan S. Anjana and
• Ramapurath S. Jayasree

Beilstein J. Nanotechnol. 2023, 14, 988–1003, doi:10.3762/bjnano.14.82

• change [20][21]. Generally, photothermal nanomaterials are being used in cancer therapy, removal of bacterial biofilms, and sensing applications [22][23][24]. Photothermal nanomaterials produce heat in response to the irradiation of photons at a particular wavelength [23]. Similarly, when plasmonic

• particle size from 50 to 4.98 nm. In another study, the size-dependent photothermal conversion efficiency of platinum nanomaterials was studied by Depciuch et al. for cancer therapy. Spherical platinum nanoparticles with diameters of 2 and 80 nm were studied regarding the photothermal activity in colon

• reduced graphene oxide (rGO), SERS imaging can be done along with photothermal therapy [84]. Recently, our group developed a multifunctional rGO–Au nanoscale architecture loaded with Raman dye and anticancer drugs for fluorescence/SERS imaging-guided breast cancer therapy. Under activation of a laser at

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• improvement, further investigations are required. Moreover, extensive research is still required in the field of clinical safety of ACNPs to evolve a highly acceptable and beneficial delivery system for cancer theranosis. Future perspectives In cancer therapy, ACNPs have several advantages related to their

• , detection, and eradication of cancer cells and biomarkers, with great potential in theranostic applications. Despite these advantages, the design and fabrication of targeted NPs for cancer therapy is still very challenging regarding biocompatibility, pharmacokinetics, in vivo targeting efficacy, and cost

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

• Filip Gorachinov,
• Fatima Mraiche,
• Diala Alhaj Moustafa,
• Ola Hishari,
• Yomna Ismail,
• Jensa Joseph,
• Maja Simonoska Crcarevska,
• Marija Glavas Dodov,
• Nikola Geskovski and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

• siRNA in the downregulation of oncogenes offers numerous advantages in combinatorial lung cancer treatment for targeting mutations that contribute to the resistance to cancer therapy. Synthetic siRNA can be designed to inhibit any target gene expression and consequently prevent or decrease target

• contribute to cancer therapy resistance encouraged the therapeutic application of RNA interference as a powerful tool to fight resistant tumors. Knockdown of oncogenic genes involved in drug resistance combined with traditional therapy or molecularly targeted agents for subsequent tumor killing may alleviate

Facile preparation of Au- and BODIPY-grafted lipid nanoparticles for synergized photothermal therapy

• Yuran Wang,
• Xudong Li,
• Haijun Chen and
• Yu Gao

Beilstein J. Nanotechnol. 2022, 13, 1432–1444, doi:10.3762/bjnano.13.118

• specificity and minimal invasiveness, it has attracted a great deal of attention as complementary modality for conventional cancer therapy options [1]. Gold nanoparticles (AuNPs) can absorb light and generate heat from light absorption because of the surface plasmon resonance (SPR) phenomenon and the tunable

• delivery systems through van der Waals forces, hydrogen bonds, π–π stacking, or electrostatic or hydrophobic interactions [24]. Several BODIPYs have been reported to be loaded into liposomes for cancer therapy [25]. Therefore, we speculated that BODIPY can be associated with our previously reported

Recent advances in green carbon dots (2015–2022): synthesis, metal ion sensing, and biological applications

• Aisha Kanwal,
• Naheed Bibi,
• Sajjad Hyder,
• Arif Muhammad,
• Hao Ren,
• Jiangtao Liu and
• Zhongli Lei

Beilstein J. Nanotechnol. 2022, 13, 1068–1107, doi:10.3762/bjnano.13.93

Engineered titania nanomaterials in advanced clinical applications

• Padmavati Sahare,
• Paulina Govea Alvarez,
• Juan Manual Sanchez Yanez,
• Gabriel Luna-Bárcenas,
• Samik Chakraborty,
• Sujay Paul and
• Miriam Estevez

Beilstein J. Nanotechnol. 2022, 13, 201–218, doi:10.3762/bjnano.13.15

• (nanotubes, nanorods, nanowhiskers, nanoflower, nanotubes, nanobelts, or nanocrystals), and topographical features such as surface area, size (1–100 nm), and uncoordinated surface sites [26]. The photocatalytic nature of titania is greatly explored in antimicrobial studies as well as in photodynamic cancer

• therapy. The cytotoxic properties of TiO2 are related to differences in phase composition. The anatase phase has a higher toxicity due to its wider bandgap and effectiveness in the generation of ROS [27]. Lower amounts of ROS, which operate as redox signaling messengers, are essential for optimal

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

• Sadaf Mushtaq,
• Khuram Shahzad,
• Tariq Saeed,
• Anwar Ul-Hamid,
• Bilal Haider Abbasi,
• Nafees Ahmad,
• Waqas Khalid,
• Muhammad Atif,
• Zulqurnain Ali and
• Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

• spheroid diameter and up to 74 ± 8.9% of cell death after two weeks. In addition, they also inhibited multidrug resistance (MDR) pump activity in both cell lines suggesting effectivity in MDR cancers. Among the tested MFe2O4 NPs, CFO nanocarriers were the most favorable for targeted cancer therapy due to

• stability, magnetic properties (coercivity = 883 and saturation magnetization = 56 emu/g), and specificity towards cancer cells support CFO nanocarriers as promising candidates for targeted cancer therapy domains. However, further investigations regarding pathway analysis, in vivo cytotoxicity, and magnetic

pH-driven enhancement of anti-tubercular drug loading on iron oxide nanoparticles for drug delivery in macrophages

• Karishma Berta Cotta,
• Sarika Mehra and
• Rajdip Bandyopadhyaya

Beilstein J. Nanotechnol. 2021, 12, 1127–1139, doi:10.3762/bjnano.12.84

• biocompatibility and magnetic properties, have found applications in drug delivery, magnetic resonance imaging and treatment of iron deficiencies [3][4][5][6]. The property of hyperthermia has been found to be beneficial in localized drug release, particularly in cancer therapy [7]. In anti-cancer therapy, IONPs

Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• that could impact the performance of CUR-based nanosystems as a cancer therapy option are also considered. Due to the large body of evidence supporting the bioactivity of CUR, it has been widely considered a suitable molecule to be encapsulated in order to increase and target its delivery. The evidence

• information, the aim of the present work is to summarize the improvements regarding anticancer effects obtained when CUR is encapsulated using various nanosized systems. Review Curcumin in cancer therapy Figure 1 summarizes the effects of CUR on cancerous processes, according to information generated from

• due to different rates of absorption and metabolism, thus, better responses may be achieved [18][39]. Curcumin nanosystems in cancer therapy Nanotechnology can improve the effects of conventional chemotherapeutic agents by reducing multidrug resistance, personalizing cancer treatment, decreasing

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

• cancer therapy [123]. Furthermore, ADV-generated MBs can provide contrast-enhanced imaging and increase the temperature during HIFU therapy due to the cavitation produced when using ultrasound contrast agents [115]. ADV-generated MBs with the proper density can facilitate uniform HIFU ablative treatment

• hyperthermia within the tumor while preserving healthy tissue from the undesirable side effects of heating [146]. The local production of heat can trigger drug release, intensify the cytotoxic effect of the loaded drugs, and eventually destroy the tumor cells. Therefore, the overall goal of cancer therapy can

Fate and transformation of silver nanoparticles in different biological conditions

• Barbara Pem,
• Marija Ćurlin,
• Darija Domazet Jurašin,
• Valerije Vrček,
• Rinea Barbir,
• Vedran Micek,
• Raluca M. Fratila,
• Jesus M. de la Fuente and
• Ivana Vinković Vrček

Beilstein J. Nanotechnol. 2021, 12, 665–679, doi:10.3762/bjnano.12.53

• , which listed more than 100 AgNP-containing food products [4]. The biomedical use of AgNPs represents the largest proportion of the market share [1] encompassing antimicrobial coatings on medical devices (catheters, stents, implants), wound dressings, targeted drug delivery, cancer therapy and

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

• simple techniques for the prediction and synthesis of native ligands for specific receptors. Advances in molecular targets for cancer therapy and their implications in nanoscale targeting strategies will be briefly presented in the following part of the article. EGFR is a member of the ErbB family of

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

• Uzma Azeem Awan,
• Abida Raza,
• Shaukat Ali,
• Rida Fatima Saeed and
• Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

• , nanorods, nanoshells, and nanocages) have great potential in photothermal cancer therapy due to plasmonic properties and the ease of biofunctionalization. Gold nanorods (GNRs) are more preferable than other gold nanomaterials because of their photothermal conversion efficiency. Better nanotherapeutics can

• be obtained by utilizing external stimuli, such as pH value, light, or ultrasound, to deliver the anti-cancerous drug into tumor tissue with spatial and temporal control [14]. Photothermal therapy (PTT) is an emerging minimally invasive cancer therapy. It can efficiently induce cytotoxicity by

• of the drug to the cells after cell uptake. The decreased cytotoxicity of DOX-PSS-GNRs is because of a delayed drug release inside cells [23]. The PSS-GNRs nanocomplex shows potential as biocompatible nanocarrier for drug loading and delivery in cancer therapy. Arunkumar et al. have reported that DOX